CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC
Trial details
- Registry ID
- NCT04681131
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as BA3011
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLCNCT04681131 | BioAtla, Inc. | Phase 2 | Completed | 2025-07-09Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |